Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Filings indexed 719 across all filing types
Latest filing 2006-04-12 Regulatory Filings
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC compound active against influenza viruses
Regulatory Filings Classification · 99% confidence The document is a press release dated April 12, 2006, announcing a cooperation between 4SC AG and the Institute of Molecular Virology regarding the development of an active agent against influenza viruses. It details scientific findings, partnership goals, and provides background information on both entities. This type of announcement, which is a general corporate update about research and development activities, does not fit the specific definitions for financial reports (10-K, IR, ER), shareholder actions (AGM-R, DVA, DIV), or management changes (MANG). It is a general corporate news item. Since it is not a formal regulatory filing like a 10-K or a specific financial report, and it is not an announcement of a report publication (RPA), the most appropriate general category for a significant, non-standard corporate announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous corporate news releases.
2006-04-12 English
4SC Wirkstoff aktiv gegen Influenza-Viren
Environmental & Social Information Classification · 99% confidence The document is a press release dated April 12, 2006, announcing a cooperation between 4SC AG and the Institute for Molecular Virology at the University of Münster regarding the development of a drug substance against influenza viruses. It details scientific findings, the scope of the collaboration, and provides background information on both entities. This type of announcement, focusing on a specific business development (a new research partnership/drug development update) that is not a mandatory periodic financial filing (like 10-K or IR) or a standard earnings release (ER), fits best under the general category for corporate news or regulatory filings that don't have a more specific code. Since it is a specific corporate announcement about a scientific/business development, and not a formal financial report, a general regulatory filing (RNS) or a specific announcement type is considered. Given the options, it is a general corporate news release about a partnership and research progress. It is not a formal financial report (10-K, IR), a management discussion (MDA), or an earnings release (ER). It is most appropriately classified as a general Regulatory Filing (RNS) as it is a public announcement of material information, or potentially a Legal/Research update, but RNS serves as the best general corporate announcement fallback when specific codes like 'CAP' (financing) or 'LTR' (legal) do not apply. Since it is a news release announcing a scientific/business development, RNS is the most suitable general category.
2006-04-12 German
4SC AG reports financial results for financial year 2005
Earnings Release Classification · 99% confidence The document is titled "4SC AG reports financial results for financial year 2005" and provides a detailed summary of the financial performance for the year 2005, including net sales, costs, operating results, earnings per share, balance sheet changes (equity, cash), and an outlook for 2006. This content structure—a summary of annual financial performance, key operational milestones, and future guidance—is characteristic of an Earnings Release (ER) or a summary preceding a full Annual Report (10-K). Since it focuses on reporting the results for a specific period (financial year 2005) and includes key financial metrics and management commentary, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results. It is not a full 10-K, nor is it merely an announcement of a report (RPA). FY 2005
2006-03-30 English
4SC AG berichtet uber den Geschaftsverlauf in 2005
Earnings Release Classification · 99% confidence The document is titled "4SC AG berichtet über den Geschäftsverlauf in 2005" (4SC AG reports on the course of business in 2005) and contains a detailed financial review ('Finanzrückblick 2005') covering revenue, costs, net result, equity, and cash position for the full year 2005, along with an outlook for 2006. This structure—a comprehensive review of a full fiscal year's performance—is characteristic of an Annual Report or a detailed Earnings Release/Management Discussion and Analysis (MDA). Since it provides extensive financial figures, operational details, and management commentary for the entire year, it aligns best with the content expected in a comprehensive annual filing, although it is presented as a news release. Given the options, the detailed financial review of a full year strongly suggests the content of a 10-K, even if this specific text is the press release summarizing it. However, since it is a news release format summarizing the full year's performance, it is often classified as an Earnings Release (ER) if it's the initial announcement, or potentially an MDA if it's the management's detailed explanation accompanying the formal filing. Because it covers the *entire* year's performance and includes a full financial summary (not just highlights), it is more comprehensive than a typical quarterly ER. It also mentions the full Annual Report can be retrieved online ("Den Geschäftsbericht können Sie unter [http://www.4sc.de](http://www.4sc.de/) abrufen"). This suggests the provided text is the press release summarizing the annual results, which is closest to an Earnings Release (ER) or Management Discussion (MDA). Given the depth of the financial review (comparing 2005 to 2004 figures across multiple lines), MDA is a strong candidate, but ER often encompasses the initial release of annual results. Since it details the full year's results and outlook, and is presented as a news item, I will classify it as an Earnings Release (ER), as it serves as the primary public announcement of the full-year financial outcome. FY 2005
2006-03-30 German
Annual Report 2005
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2005' and contains detailed financial data such as net sales, operating results, earnings per share, equity, balance sheet totals, cash flows, and number of employees. It includes sections like 'Management Report', 'Financial Statements (IFRS)', 'Auditors' report', 'Report of the Supervisory Board', 'Corporate governance report', and 'Remuneration report'. The content covers a full fiscal year with comprehensive financial performance and business activities. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement. These characteristics align with the definition of an Annual Report (10-K).
2006-03-30 English
Annual Report 2005
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2005' and contains comprehensive financial statements (Income statement, Balance sheet, Cash flow statement), a management report, auditor's report, and a letter to shareholders. It covers the full fiscal year 2005 and provides detailed financial and operational performance data, fitting the definition of an Annual Report (10-K). FY 2005
2006-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.